Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain
Open Access
- 22 July 2025
- journal article
- research article
- Published by Springer Nature in EJNMMI Research
- Vol. 15 (1) , 1-10
Abstract
The large neutral amino acid [18F]fluoroethoxy-L-tyrosine ([18F]FET) is a popular tracer for detection and staging of intracranial tumors by positron emission tomography (PET). While its high tumoral uptake reflects over-expression of the L-type amino acid transporter (LAT1), there is little knowledge about the kinetics of [18F]FET uptake in healthy brain tissue, owing to the limited PET data in healthy volunteers, and to the requirement of an arterial input function for compartmental analysis. To address this, we used long axial field-of-view (LAFOV) dynamic 40-min recordings of 28 post-operative patients with intracranial tumors to undertake parametric brain mapping relative to an image-derived arterial input function (IDIF) obtained from the aorta. We averaged the individual parametric maps to obtain estimates of the physiological uptake relatively unaffected by individual residual lesions and resections, and tested simplified single-frame methods for quantitation. The analyses yielded estimates of regional unidirectional blood–brain clearance K1 (0.00825–0.0244 ml g−1 min−1), net blood–brain clearance Kin (0.00448–0.00913 ml g−1 min−1), and equilibrium distribution volume VT (0.126–0.495 ml g−1), where the lowest values depict white matter, and the highest values cerebellum. In our test of a simplified quantitation of [18F]FET uptake from single frame recordings, i.e., Gjedde–Patlak multilinear graphic analyses of K1 at five min post-injection and Kin at 40 min post injection, results were in good agreement with the analyses from the dynamic recordings (< 10% error). Compartmental analysis results for [18F]FET uptake in extra-tumoral human brain regions are in accord with the few prior reports, mainly obtained in experimental animals, and support the use of single frame quantitation. Present findings in relatively healthy brain should inform the interpretation of pathological [18F]FET uptake in tumors.Keywords
Funding Information
- Eidgenössische Technische Hochschule Zürich (MedLab Fellowship 2023)
- International Centers for Precision Oncology Foundation (Research Grant)
This publication has 35 references indexed in Scilit:
- Total-body PET/CT or LAFOV PET/CT? Axial field-of-view clinical classificationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06European Journal of Nuclear Medicine and Molecular Imaging, 2023
- First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomasJournal of Neuro-Oncology, 2010
- High expression of L-type amino acid transporter 1 in infiltrating glioma cellsBrain Tumor Pathology, 2005
- O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosineEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Pharmacokinetics of radiotracers in human plasma during positron emission tomographySynapse, 1999